Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Japan open-label linerixibat safety and tolerability extension study for cholestatic pruritus in primary biliary cholangitis
jRCT2011260052Recruiting
- Sponsor
- Alfasigma
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of linerixibat, sponsored by Alfasigma. Started Oct 2026; status: recruiting.
02
Drugs
linerixibat
Beyond the preview
Go deeper on jRCT2011260052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2011260052.